Drug Hypersensitivity Syndrome
"Drug Hypersensitivity Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Severe drug eruption characterized by high fever, erythematous rash and inflammation of internal organ(s).
| Descriptor ID |
D063926
|
| MeSH Number(s) |
C17.800.174.600.262 C20.543.206.380.262 C25.100.468.380.262
|
| Concept/Terms |
Drug Hypersensitivity Syndrome- Drug Hypersensitivity Syndrome
- Drug Hypersensitivity Syndromes
- Hypersensitivity Syndrome, Drug
- Hypersensitivity Syndromes, Drug
- Syndrome, Drug Hypersensitivity
- Syndromes, Drug Hypersensitivity
- DRESS Syndrome
- DRESS Syndromes
- Drug Reaction with Eosinophilia and Systemic Symptoms
- Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome
|
Below are MeSH descriptors whose meaning is more general than "Drug Hypersensitivity Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Drug Hypersensitivity Syndrome".
This graph shows the total number of publications written about "Drug Hypersensitivity Syndrome" by people in this website by year, and whether "Drug Hypersensitivity Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 1 | 0 | 1 |
| 2017 | 4 | 1 | 5 |
| 2018 | 6 | 0 | 6 |
| 2019 | 2 | 0 | 2 |
| 2020 | 2 | 0 | 2 |
| 2021 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Drug Hypersensitivity Syndrome" by people in Profiles.
-
Drug reaction with eosinophilia and systemic symptoms (DRESS) in patients with COVID-19. Clin Microbiol Infect. 2021 08; 27(8):1190-1192.
-
Life-threatening DRESS syndrome with kidney damage following severe COVID-19 in a patient with Down syndrome. BMJ Case Rep. 2021 Apr 19; 14(4).
-
Follow-up of skin lesions during COVID-19: a description of a DRESS case. Arch Dermatol Res. 2021 09; 313(7):607-610.
-
Detection of SARS-CoV-2 in a case of DRESS by sulfasalazine: could there be a relationship with clinical importance? Int J Dermatol. 2021 Jan; 60(1):125-126.
-
Comment on 'Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID-19': involvement of herpesvirus reactivations and adverse drug reactions in diverse cutaneous manifestations and overall disease severity of COVID-19. J Eur Acad Dermatol Venereol. 2021 02; 35(2):e98-e100.
-
Benralizumab for severe DRESS in two COVID-19 patients. J Allergy Clin Immunol Pract. 2021 01; 9(1):481-483.e2.
-
Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID-19. J Eur Acad Dermatol Venereol. 2020 Dec; 34(12):e768-e700.
-
First case of DRESS syndrome caused by hydroxychloroquine with a positive patch test. Contact Dermatitis. 2021 01; 84(1):50-51.
-
Drug reaction with eosinophilia and systemic symptoms syndrome to hydroxychloroquine, an old drug in the spotlight in the COVID-19 era. Dermatol Ther. 2020 Jul; 33(4):e13499.
-
[DRESS syndrome simulating coronavirus 2019-NcoV disease]. Semergen. 2021 Jan-Feb; 47(1):56-58.